AFLAC INC
AFLNYSETrading Snapshot
- Day Range
- $111.49 – $115.20
- 52-Week Range
- $105.43 – $130.22
- Volume
- $3.82B
- Avg Volume
- $4.11B
- Shares Outstanding
- 509.0M
- Next Earnings
- Oct 30, 2026
Fundamentals Snapshot
- Annual Revenue
- $17.44B
- Last Q Revenue
- $4.08B
- P/E Ratio
- 12.2
- P/S Ratio
- 3.2x
- EPS (TTM)
- $9.64
- Dividend Yield
- 2.12%
- Dilution (1yr)
- −5.8%
Why Investors Own AFL
- ✓High-growth profile — revenue up +30.9% YoY with expanding US Equity exposure.
- ✓Healthy economics — 77% gross margin and 16% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
AFLAC INC
AFL
StockOtter · stockotter.spaceAbout AFLAC INC
Aflac Incorporated, operating through its various subsidiary companies, focuses on delivering supplementary health and life insurance policies. The firm's business activities are structured into two primary divisions: Aflac Japan and Aflac U.S. In Japan, the company offers a diverse range of insurance products, including coverage for cancer, medical expenses, income support for nursing care, and the distinct GIFT plan. This segment also provides traditional whole and term life insurance, along with savings-oriented plans like WAYS and child endowment products. Meanwhile, the Aflac U.S. division caters to the American market, furnishing policies that address cancer, accidents, short-term disability, critical illness, and hospital stays. Additionally, it provides dental, vision, long-term care, disability, and both term and whole life insurance options. Aflac distributes its comprehensive suite of products through multiple channels, which include dedicated sales associates, independent brokers, various corporate and individual agencies, and affiliated agencies. Established in 1955, the company maintains its corporate headquarters in Columbus, Georgia.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Aflac (NYSE:AFL) Major Shareholder Post Holdings Co. Ltd. Japan Sells 12,200 Shares of Stock
Aflac Incorporated (NYSE: AFL - Get Free Report) major shareholder Post Holdings Co. Ltd. Japan sold 12,200 shares of the company's stock in a transaction dated Monday, September 21st. The shares were sold at an average
4 Insurance Stocks With Two Big Profit Engines Backing the Dividend
Most retirees overlook insurance stocks entirely, but a select group of insurers collect a paycheck twice before writing a single dividend check. Here is why that double engine makes all the difference for income durabil
Aflac (NYSE:AFL) Major Shareholder Post Holdings Co. Ltd. Japan Sells 12,800 Shares of Stock
Aflac Incorporated (NYSE: AFL - Get Free Report) major shareholder Post Holdings Co. Ltd. Japan sold 12,800 shares of the company's stock in a transaction dated Friday, September 18th. The shares were sold at an average
Former baseball and football star Brian Jordan and Aflac President Virgil Miller join forces to show love and care to children and families at SSM Health Cardinal Glennon Children's Hospital in St. Louis
Legendary athlete and children's book author read his book for patients and helped deliver My Special Aflac Duck ® to children with cancer and sickle cell disease ST. LOUIS, Sept.
Aflac + Rachel Zoe make bold fashion statement to prompt Americans to Check for Cancer
Rachel Zoe's unique designed jacket features a checked pattern scannable code to drive increase in cancer screenings COLUMBUS, Ga., Sept. 22, 2026 /PRNewswire/ -- A pioneer in cancer insurance, Aflac has spent seven deca
Brokerages Set Aflac Incorporated (NYSE:AFL) Price Target at $116.62
Aflac Incorporated (NYSE: AFL - Get Free Report) has been given an average recommendation of "Hold" by the fourteen analysts that are covering the company, MarketBeat.com reports. Three investment analysts have rated the